Copyright © MRI Scan Proscan Imaging Buffalo, medical clinic and doctors office. All rights reserved.
There is progress in prostate cancer detection leading to reduced intervention and improved accuracy of diagnosis and treatment. The single most important factor in this change is the addition of multiparametric MRI (mpMRI). Scientific evidence has shown that mpMRI can help determine if a biopsy is necessary. This means sparing men from conventional TRUS-guided biopsy which are frequently inaccurate. On the other hand, if mpMRI detects a suspicious area, a 3T mpMRI Fusion Guided Target Biopsy facilitates pinpoint diagnosis.
According to a newly published article, “Prebiopsy MRI followed by targeted biopsy appears to have the ability to overcome the limitations of the standard 12-core template biopsy.” The authors of the review point out that both the American Urological Association and the Society of Abdominal Radiology have issued consensus statements on the utilization of mpMRI prior to biopsy. Such statements confirm that 3T mpMRI with standardized PI-RADS interpretation integrated with a 3T mpMRI Fusion Guided Target Biopsy yields the bestoutcomes when diagnosing prostate cancer.
The Proscan Center of Excellence in Prostate Cancer Detection is a recognized leader in 3T mpMRI. Our team of experts is dedicated to providing the most complete prostate cancer care available and the most comprehensive diagnostic testing for prostate cancer diagnosis.
Contact us for more information.